Tag:
Levemir
Latest Headlines
Latest Headlines
Mixed data for Novo's diabetes drug
Novo Nordisk's long-lasting insulin drug Levemir turned in mixed results in a Phase III trial. Bad news first: Patients taking the drug were less likely to achieve blood sugar control than those
